NCT03752034

Muscle Fiber Fragments for Improved Function of Rotator Cuff Musculature Following Rotator Cuff Repair

Recruiting
NAAges 40–80InterventionalTreatment
Wake Forest University Health Sciences
~20 participants
Updated 2026-03-27 on ClinicalTrials.gov
What's tested:Muscle Fiber Fragments (MFFs)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of Adverse Events
Measured over 6 months post surgery
+1 more outcome measured
Rotator Cuff

NCT03752034

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolinastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Gary G Poehling, MD · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Males and females, ages 40 to 80 years
Unilateral Disease
\< 1.5cm tear

Exclusion

Diabetes
Peripheral Neuropathy
Previous Shoulder Surgery
Pain Syndrome; cuff arthroplasty
Major co-morbidities including, but not limited to, uncontrolled diabetes, cardiovascular, pulmonary, GI, coagulopathies
Arthritis of Shoulder
Unwilling or unable to comply with post-operative instructions or follow-up visits
Auto Immune Disease
Complete Subscapularis Tear
Teres Minor involvement
History of testing positive for HIV, Hep B, Hep C, HTLV-1, HTLV-2
Pregnancy
Implanted devices containing ferromagnetic material
Any implanted electrical stimulation devices (i.e. cochlear implant, defibrillator)
Any other condition which the PI feels would be not in the best interest for the patient or the study
  • Incidence of Adverse Events6 months post surgery

    The incidence of adverse events will be documented in the areas of product related, biopsy procedure-related, and injection-related reporting for each group.

  • Incidence of Adverse Events12 months post surgery

    The incidence of adverse events will be documented in the areas of product related, biopsy procedure-related, and injection-related reporting for each group.